Format
Sort by
Items per page

Send to

Choose Destination

Best matches for PRASTERONE/AE:

Prasterone. Kocis P et al. Am J Health Syst Pharm. (2006)

Prasterone (Intrarosa) for dyspareunia. et al. Med Lett Drugs Ther. (2017)

Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway. Zhao H et al. Daru. (2017)

Search results

Items: 1 to 20 of 195

1.

Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial.

Wang W, Liu H, Li J, Wei D, Zhang J, Wang J, Ma J, Shi Y, Chen ZJ.

Trials. 2019 Jan 15;20(1):50. doi: 10.1186/s13063-018-3146-x.

2.

MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.

Zhou DN, Li SJ, Ding JL, Yin TL, Yang J, Ye H.

Curr Med Sci. 2018 Oct;38(5):853-860. doi: 10.1007/s11596-018-1953-7. Epub 2018 Oct 20.

PMID:
30341520
3.

Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.

Furat Rencber S, Kurnaz Ozbek S, Eraldemır C, Sezer Z, Kum T, Ceylan S, Guzel E.

J Ovarian Res. 2018 Jun 29;11(1):55. doi: 10.1186/s13048-018-0427-7.

4.

Effects of dehydroepiandrosterone on the ovarian reserve and pregnancy outcomes in perimenopausal rats (DHEA and fertility in perimenopausal rats).

Mahmoud YI, Mahmoud AA, Abo-Zeid FS, Fares NH.

Life Sci. 2018 Apr 15;199:131-138. doi: 10.1016/j.lfs.2018.03.021. Epub 2018 Mar 9.

PMID:
29526798
5.

The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.

Wong QHY, Yeung TWY, Yung SSF, Ko JKY, Li HWR, Ng EHY.

J Assist Reprod Genet. 2018 May;35(5):857-862. doi: 10.1007/s10815-018-1152-2. Epub 2018 Mar 9.

6.

DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway.

Wang D, Wang W, Liang Q, He X, Xia Y, Shen S, Wang H, Gao Q, Wang Y.

J Ovarian Res. 2018 Jan 10;11(1):6. doi: 10.1186/s13048-017-0375-7.

7.

Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study.

Çelik LS, Kuyucu Y, Yenilmez ED, Tuli A, Dağlıoğlu K, Mete UÖ.

Ultrastruct Pathol. 2018 Jan-Feb;42(1):55-64. doi: 10.1080/01913123.2017.1385668. Epub 2017 Dec 1.

PMID:
29192811
8.

Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.

Zhao H, Zhou D, Chen Y, Liu D, Chu S, Zhang S.

Daru. 2017 Oct 11;25(1):21. doi: 10.1186/s40199-017-0188-7.

9.

Prasterone (Intrarosa) for dyspareunia.

[No authors listed]

Med Lett Drugs Ther. 2017 Sep 11;59(1529):149-150. No abstract available.

PMID:
28880846
10.

ATP synthase β-subunit abnormality in pancreas islets of rats with polycystic ovary syndrome and type 2 diabetes mellitus.

Li W, Li SJ, Yin TL, Yang J, Cheng Y.

J Huazhong Univ Sci Technolog Med Sci. 2017 Apr;37(2):210-216. doi: 10.1007/s11596-017-1717-9. Epub 2017 Apr 11.

PMID:
28397049
11.

Potential prevention by oral DHEA of superficial tears in elderly atrophic skin.

Daniell HW.

J Steroid Biochem Mol Biol. 2017 Jul;171:155-156. doi: 10.1016/j.jsbmb.2017.03.007. Epub 2017 Mar 12.

PMID:
28300625
12.

Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults.

Huang Y, Gao JM, Zhang CM, Zhao HC, Zhao Y, Li R, Yu Y, Qiao J.

Reproduction. 2016 Dec;152(6):705-714.

13.

Depression-Like Behavior in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.

Yu Q, Hao S, Wang H, Song X, Shen Q, Kang J.

Biol Reprod. 2016 Oct;95(4):79. Epub 2016 Aug 24.

PMID:
27557647
14.

Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.

Contraception. 2017 Nov;96(5):322-329. doi: 10.1016/j.contraception.2016.06.022. Epub 2016 Jul 5.

15.

Peripheral neurosteroids enhance P2X receptor-induced mechanical allodynia via a sigma-1 receptor-mediated mechanism.

Kwon SG, Yoon SY, Roh DH, Choi SR, Choi HS, Moon JY, Kang SY, Beitz AJ, Lee JH.

Brain Res Bull. 2016 Mar;121:227-32. doi: 10.1016/j.brainresbull.2016.02.012. Epub 2016 Feb 11.

PMID:
26876754
16.

High-fat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS.

Zhang H, Yi M, Zhang Y, Jin H, Zhang W, Yang J, Yan L, Li R, Zhao Y, Qiao J.

Reproduction. 2016 Apr;151(4):431-41. doi: 10.1530/REP-15-0542. Epub 2016 Jan 26.

PMID:
26814210
17.

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.

Bouchard C, Labrie F, Derogatis L, Girard G, Ayotte N, Gallagher J, Cusan L, Archer DF, Portman D, Lavoie L, Beauregard A, Côté I, Martel C, Vaillancourt M, Balser J, Moyneur E; VVA Prasterone Group.

Horm Mol Biol Clin Investig. 2016 Mar;25(3):181-90. doi: 10.1515/hmbci-2015-0044.

18.

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.

Nagels HE, Rishworth JR, Siristatidis CS, Kroon B.

Cochrane Database Syst Rev. 2015 Nov 26;(11):CD009749. doi: 10.1002/14651858.CD009749.pub2. Review.

PMID:
26608695
19.

Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.

Tessaro I, Modina SC, Franciosi F, Sivelli G, Terzaghi L, Lodde V, Luciano AM.

J Ovarian Res. 2015 Oct 6;8:64. doi: 10.1186/s13048-015-0192-9.

20.

High-dose testosterone and dehydroepiandrosterone induce cardiotoxicity in rats: Assessment of echocardiographic, morphologic, and oxidative stress parameters.

Emer E, Yildiz O, Seyrek M, Demirkol S, Topal T, Kurt B, Sayal A.

Hum Exp Toxicol. 2016 May;35(5):562-72. doi: 10.1177/0960327115595706. Epub 2015 Jul 21.

PMID:
26199281

Supplemental Content

Loading ...
Support Center